A randomised parallel group double blind placebo-controlled dose ranging Trial of low dose adjunctive alTeplase during priMary PCI (T-TIME)

McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick A H, Appleby C, Cotton J M, Wragg A, Curzen N, Oldroyd K G, Lindsay M, Rocchiccioli J P, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Ford TJ, Petrie MC, Macfarlane PW, Tait RC, Welsh P, Sattar N, Weir RA, Fox KA, Ford I, McConnachie A, Berry C
Record ID 32015000753
English
Details
Project Status: Completed
URL for project: https://www.journalslibrary.nihr.ac.uk/programmes/eme/1217045/#/
Year Published: 2020
URL for published report: https://www.journalslibrary.nihr.ac.uk/programmes/eme/1217045/#/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Percutaneous Coronary Intervention
  • Tissue Plasminogen Activator
  • Drug Therapy, Combination
  • Dose-Response Relationship, Drug
  • Fibrinolytic Agents
  • Myocardial Ischemia
Contact
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.